XXII 22nd Century Group Inc.

22nd Century Group to Announce First Quarter 2020 Financial Results on May 7, 2020

22nd Century Group to Announce First Quarter 2020 Financial Results on May 7, 2020

Williamsville, NY, April 28, 2020 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII) (“22nd Century” or “the Company”), a leading plant biotechnology company focused on reduced nicotine tobacco and hemp/cannabis plant genetics research and development, will release first quarter 2020 financial results on Thursday, May 7, 2020, before the market opens. The press release will be available on 22nd Century Group’s website at . In conjunction with the earnings release, the Company will host a conference call on Thursday, May 7, 2020, at 8:00 a.m. ET.

The live audio webcast will be accessible in the Events section on the Company's Investor Relations website at . Participants may also listen to the live call by dialing (877) 407-6914. A replay of the call will be available until May 21, 2020 by dialing (877) 660-6853; the passcode is 13702417. An archived replay of the webcast will also be available shortly after the live event has concluded.

Investors, analysts and members of the media interested in submitting questions in advance can do so by sending an e-mail to .

About 22nd Century Group, Inc.

22nd Century Group, Inc. (NYSE AMERICAN: XXII) is a leading plant biotechnology company focused on technologies that alter the level of nicotine in tobacco plants and the level of cannabinoids in hemp/cannabis plants through genetic engineering, gene-editing and modern plant breeding. The Company’s primary mission in tobacco is to reduce the harm caused by smoking by bringing its proprietary reduced nicotine content cigarettes with 95% less nicotine than conventional cigarettes to adult smokers in the U.S. and international markets. The Company’s primary mission in hemp/cannabis is to develop proprietary hemp/cannabis plants with unique cannabinoid profiles and desirable agronomic traits and to commercialize those plants through a synergistic portfolio of strategic partnerships in the hemp/cannabis industry.

Learn more at , on Twitter  and on .

 

###

 

Mei Kuo
22nd Century Group, Inc.
(716) 300-1221
 

John Mills
ICR
(646) 277-1254
 

Deirdre Thomson
ICR
(646) 277-1283
 
EN
28/04/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on 22nd Century Group Inc.

 PRESS RELEASE

22nd Century Secures $3.2 Million to Date in Warrant Exchange Transact...

22nd Century Secures $3.2 Million to Date in Warrant Exchange Transaction Newly Appointed CEO Leading Restructuring to Focus on Tobacco Industry Operations, Reduce Costs BUFFALO, N.Y., Dec. 04, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII) (the “Company”), a biotechnology company focused on utilizing advanced plant technologies to improve health and wellness, today announced the exercise of warrants by certain holders pursuant to its previously announced warrant inducement offering. During the inducement period, certain holders of the Company’s existing warrants acqui...

 PRESS RELEASE

22nd Century Appoints Larry Firestone as Chairman and CEO

22nd Century Appoints Larry Firestone as Chairman and CEO Turnaround Veteran to Focus on Unlocking Shareholder Value in Tobacco Assets BUFFALO, N.Y., Nov. 29, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII) (“22nd Century” or the “Company”), a biotechnology company focused on utilizing advanced plant technologies to improve health and wellness, today announced the appointment of Lawrence (Larry) Firestone as the Company's Chairman and Chief Executive Officer. Nora Sullivan, former Chair of the Board, commented, “Larry is a seasoned executive known for his 'hands-on...

 PRESS RELEASE

22nd Century Group Enters into Agreement to Sell Hemp/Cannabis Franchi...

22nd Century Group Enters into Agreement to Sell Hemp/Cannabis Franchise Sale Expected to Result in Immediate and Significant Reduction in Operating Costs and Cash Requirements BUFFALO, N.Y., Nov. 27, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: ) (the “Company” or “22nd Century”), a leading biotechnology company focused on utilizing advanced plant technologies to improve health and wellness, today announced it has reached an agreement to sell substantially all of its GVB Biopharma (“GVB”) hemp/cannabis operations to Specialty Acquisition Corporation, a Nevada corporation ...

 PRESS RELEASE

22nd Century Group Continues VLN® Expansion, Now Retailing in More Tha...

22nd Century Group Continues VLN® Expansion, Now Retailing in More Than 5,100 Stores Adds another 500+ stores BUFFALO, N.Y., Nov. 08, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: ), a leading biotechnology company focused on utilizing advanced plant technologies to improve health and wellness with reduced nicotine tobacco, hemp/cannabis and hops, today announced that it has again expanded its VLN® retail presence with more than 500 additional locations across 11 states. With these latest additions, 22nd Century Group’s FDA-authorized VLN® reduced nicotine content cigarett...

 PRESS RELEASE

22nd Century Group (XXII) Expands Reduced Nicotine Content Tobacco IP ...

22nd Century Group (XXII) Expands Reduced Nicotine Content Tobacco IP with Latest Technology License Additional Exclusive License with NCSU Further Expands Reduced Nicotine Content Plant Breeding Capabilities BUFFALO, N.Y., Nov. 07, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: ), a leading biotechnology company focused on utilizing advanced plant technologies to improve health and wellness with reduced nicotine tobacco, hemp/cannabis, and hops, today announced the signing of an additional reduced nicotine content technology license with North Carolina State University. The...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch